期刊文献+

比伐芦定联合经皮冠状动脉介入治疗冠心病效果观察 被引量:3

下载PDF
导出
摘要 经皮冠状动脉介入治疗(PCI)是国际认证的治疗冠心病较为理想的方法,冠心病患者体内冠状动脉严重阻塞,以致供血不足,临床治疗就需将带有球囊扩张器的导管介入其中,起到改善心肌供血的效果[1]。研究显示,该手术的实施可显著降低冠心病患者死亡率,但由于术前心肌缺血及手术带来的创伤均对患者预后造成负面影响。
作者 蒋青峰
出处 《中国药物与临床》 CAS 2020年第11期1885-1887,共3页 Chinese Remedies & Clinics
  • 相关文献

参考文献10

二级参考文献91

  • 1柯元南.急性冠状动脉综合征诊断和治疗进展[J].中华老年心脑血管病杂志,2006,8(1):2-4. 被引量:23
  • 2无.慢性稳定性心绞痛诊断与治疗指南[J].中华心血管病杂志,2007,35(3):195-206. 被引量:2057
  • 3Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/ SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions [ J ] . Catheter Cardiovasc Interv,2013,82 (4) : E266 -355.
  • 4Montalescot G, Cohen M, Salette G, et al. Impact of anticoagulation levels on outcomes in patients undergoing elective percutaneous coronary intervention : insights from the STEEPLE trial [ J ]. Eur Heart J,2008,29(4) :462-471.
  • 5Chew DP, Bhatt DL, Lincoff AM, et al. Defining the optimal activated clotting time during percutaneous coronary intervention: aggregate results from 6 randomized, controlled trials [J]. Circulation ,2001,103 (7) :961-966.
  • 6Brener SJ, Moliterno D J, Lincoff AM, et al. Relationship between activated clotting time and ischemic or hemorrhagic complications: analysis of 4 recent randomized clinical trials of percutaneous coronary intervention [J]. Circulation, 2004,110 ( 8 ) : 994 -998.
  • 7Hillegass WB, Brott BC, Chapman GD,et al. Relationship between activated clotting time during percutaneous intervention and subsequent bleeding complications [J]. Am Heart J, 2002, 144 (3) :501-507.
  • 8Smith SC Jr, Feldman TE, Hirshfeld JW Jr, et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines ( ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention) [ J] . Circulation, 2006, 113 (7) : e166- 286.
  • 9O'Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardialinfarction : executive summary : a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines [ J ]. J Am Coll Cardiol, 2013,61 ( 4 ) : 485- 510.
  • 10Montalescot G, White HD, Gallo R, et al. Enoxaparin versus unfraetionated heparin in elective percutaneous coronary intervention[ J]. N Engl J Med,2006,355 (10) :1006-1017.

共引文献402

同被引文献45

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部